The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Debt-to-Equity : 0.00 (As of . 20)

The IBN SINA Pharmaceutical Industry Debt-to-Equity Chart

Competitive Comparison of The IBN SINA Pharmaceutical Industry's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The IBN SINA Pharmaceutical Industry's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's Debt-to-Equity falls into.

The IBN SINA Pharmaceutical Industry Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

The IBN SINA Pharmaceutical Industry's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

The IBN SINA Pharmaceutical Industry's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

The IBN SINA Pharmaceutical Industry Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description